verified SJR 1,162 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Taylor and Francis Ltd.

workspace_premium Q1 — Neuroscience (miscellaneous) lock Subscription

Expert Review of Neurotherapeutics

Expert Review of Neurotherapeutics is a journal indexed in SJR in Neuroscience (miscellaneous) and Neurology (clinical) with an H index of 103. It has a price of 2395 €. It has an SJR impact factor of 1,162 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,162.

Expert Review of Neurotherapeutics focuses its scope in these topics and keywords: treatment, obsessive, sclerosis, syndrome, multiple, genomics, exercise, dopamine, children, therapy, ...

ISSN: 1473-7175

Publisher: Taylor and Francis Ltd.

Category: Neuroscience (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,162 Q1

H-index 103

Acceptance rate pie_chart

26% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.395 € Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,162

H-index

103

Docs (year)

107

Docs 3y

309

Total refs

9276

Cites 3y

1112

Citable 3y

281

Cites/Doc 2y

3.3

Ref/Doc

86.69

Immediate OA

2395 €

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Behavioral treatment of insomnia

Ziprasidone HCl capsules for the adjunctive maintenance treatment of bipolar disorder in adults

Clomipramine use in obsessive-compulsive disorder

Chronic migraine and medication overuse: still a debate

Chronic inflammation in Alzheimer's disease offers therapeutic opportunities

Childhood multiple sclerosis: course and management

Childhood craniopharyngioma: current controversies on management in diagnostics, treatment and follow-up

Charting a path toward combination therapy for Alzheimer's disease

Changing paradigms for targeted therapies against diffuse infiltrative gliomas: tackling a moving target

Challenging views of Alzheimer's disease

Buspirone in Alzheimer's disease

Bupropion for attentiondeficit hyperactivity and comorbid disorders

SHOW MORE ARTICLES

Botulinum toxin type B (Myobloc‚Ñ¢, NeuroBloc‚Ñ¢): a new choice in cervical dystonia

Adenosine as a neuroprotectant: therapeutic perspectives

Atypical' antipsychotics: where does ziprasidone fit?

Atypical antipsychotics: revolutionary or incremental advance?

Atypical antipsychotics in the treatment of schizophrenic patients

Atypical antipsychotics in the therapy of bipolar disorders: efficacy and safety

Antiepileptic drugs in the treatment of neuropathic pain

An update on intracerebral stem cell grafts

An evaluation of the clinical application of the DSM-5 for the diagnosis of autism spectrum disorder

Alzheimer's disease from researcher to caregiver: a personal journey and call to action

Almotriptan: a novel 5-HT1B/D agonist for the symptomatic treatment of migraine

Adverse effects in the treatment of Parkinson's disease

FAQs

Expert Review of Neurotherapeutics has an SJR of 1,162 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 2395 EUR.

The acceptance rate recorded for Expert Review of Neurotherapeutics is 26%.

Expert Review of Neurotherapeutics

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Expert Review of Neurotherapeutics?

What is the APC / publication cost?

What is the acceptance rate?